These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


638 related items for PubMed ID: 22944128

  • 1. [Association between the synovial expression of cyclic citrullinated peptide and susceptibility variants of HLA-DRB1 shared epitope alleles and PADI 4 gene single nucleotide polymorphisms in patients with rheumatoid arthritis].
    Li HB, Tie N, Jia YF, Shi L, Su Y, Zhang GZ, Wang Y, Bai LJ, Zhao J, Wang J, Xiao Z.
    Zhonghua Yi Xue Za Zhi; 2012 Jun 19; 92(23):1607-11. PubMed ID: 22944128
    [Abstract] [Full Text] [Related]

  • 2. Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study.
    Bang SY, Han TU, Choi CB, Sung YK, Bae SC, Kang C.
    Arthritis Res Ther; 2010 Jun 19; 12(3):R115. PubMed ID: 20537173
    [Abstract] [Full Text] [Related]

  • 3. Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis.
    Cha S, Choi CB, Han TU, Kang CP, Kang C, Bae SC.
    Arthritis Rheum; 2007 May 19; 56(5):1454-63. PubMed ID: 17469103
    [Abstract] [Full Text] [Related]

  • 4. Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis.
    Poór G, Nagy ZB, Schmidt Z, Brózik M, Merétey K, Gergely P.
    Ann N Y Acad Sci; 2007 Sep 19; 1110():23-32. PubMed ID: 17911417
    [Abstract] [Full Text] [Related]

  • 5. [Association of the PADI4 gene polymorphism and HLA-DRB1 shared epitope alleles with rheumatoid arthritis].
    Fan LY, Zong M, Lu TB, Yang L, Ding YY, Ma JW.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Feb 19; 26(1):57-61. PubMed ID: 19199253
    [Abstract] [Full Text] [Related]

  • 6. Polymorphisms and functional haplotype in PADI4: further evidence for contribution on rheumatoid arthritis susceptibility and anti-cyclic citrullinated peptide antibodies in a western Mexican population.
    Guzmán-Guzmán IP, Reyes-Castillo Z, Muñoz-Barrios S, Ruiz-Noa Y, Martínez-Bonilla GE, Parra-Rojas I, Palafox-Sánchez CA, Muñoz-Valle JF.
    Immunol Lett; 2015 Feb 19; 163(2):214-20. PubMed ID: 25562673
    [Abstract] [Full Text] [Related]

  • 7. Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study.
    Hoppe B, Häupl T, Gruber R, Kiesewetter H, Burmester GR, Salama A, Dörner T.
    Arthritis Res Ther; 2006 Feb 19; 8(2):R34. PubMed ID: 16469113
    [Abstract] [Full Text] [Related]

  • 8. Contribution of anti-CCP antibodies, proximal interphalangeal joint involvement, HLA-DRB1 shared epitope, and PADI4 as risk factors for the development of rheumatoid arthritis in palindromic rheumatism.
    Tamai M, Kawakami A, Iwamoto N, Arima K, Aoyagi K, Eguchi K.
    Scand J Rheumatol; 2010 Aug 19; 39(4):287-91. PubMed ID: 20476860
    [Abstract] [Full Text] [Related]

  • 9. A functional haplotype of PADI4 gene in rheumatoid arthritis: positive correlation in a French population.
    Gandjbakhch F, Fajardy I, Ferré B, Dubucquoi S, Flipo RM, Roger N, Solau-Gervais E.
    J Rheumatol; 2009 May 19; 36(5):881-6. PubMed ID: 19332633
    [Abstract] [Full Text] [Related]

  • 10. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
    van Gaalen FA, van Aken J, Huizinga TW, Schreuder GM, Breedveld FC, Zanelli E, van Venrooij WJ, Verweij CL, Toes RE, de Vries RR.
    Arthritis Rheum; 2004 Jul 19; 50(7):2113-21. PubMed ID: 15248208
    [Abstract] [Full Text] [Related]

  • 11. Association of anti-cyclic citrullinated peptide antibodies and rheumatoid factor isotypes with HLA-DRB1 shared epitope alleles in Egyptian rheumatoid arthritis patients.
    Raslan HM, Attia HR, Hamed Ibrahim M, Mahmoud Hassan E, Salama II, Ismail S, Abdelmotaleb E, El Menyawi MM, Amr KS.
    Int J Rheum Dis; 2020 May 19; 23(5):647-653. PubMed ID: 32167241
    [Abstract] [Full Text] [Related]

  • 12. Interaction of HLA-DRB1*09:01 and *04:05 with smoking suggests distinctive mechanisms of rheumatoid arthritis susceptibility beyond the shared epitope.
    Bang SY, Lee HS, Lee KW, Bae SC.
    J Rheumatol; 2013 Jul 19; 40(7):1054-62. PubMed ID: 23637323
    [Abstract] [Full Text] [Related]

  • 13. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status.
    Bang SY, Lee KH, Cho SK, Lee HS, Lee KW, Bae SC.
    Arthritis Rheum; 2010 Feb 19; 62(2):369-77. PubMed ID: 20112396
    [Abstract] [Full Text] [Related]

  • 14. Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis.
    Hoppe B, Häupl T, Egerer K, Gruber R, Kiesewetter H, Salama A, Burmester GR, Dörner T.
    Ann Rheum Dis; 2009 Jun 19; 68(6):898-903. PubMed ID: 18633125
    [Abstract] [Full Text] [Related]

  • 15. HLA-DRB1 shared epitope alleles in patients with rheumatoid arthritis: relation to autoantibodies and disease severity in a south Indian population.
    Konda Mohan V, Ganesan N, Gopalakrishnan R, Venkatesan V.
    Int J Rheum Dis; 2017 Oct 19; 20(10):1492-1498. PubMed ID: 27943654
    [Abstract] [Full Text] [Related]

  • 16. A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans.
    Kang CP, Lee HS, Ju H, Cho H, Kang C, Bae SC.
    Arthritis Rheum; 2006 Jan 19; 54(1):90-6. PubMed ID: 16385500
    [Abstract] [Full Text] [Related]

  • 17. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
    Reyes-Castillo Z, Palafox-Sánchez CA, Parra-Rojas I, Martínez-Bonilla GE, del Toro-Arreola S, Ramírez-Dueñas MG, Ocampo-Bermudes G, Muñoz-Valle JF.
    Clin Exp Immunol; 2015 Nov 19; 182(2):119-31. PubMed ID: 26149185
    [Abstract] [Full Text] [Related]

  • 18. PADI4 Polymorphisms Confer Risk of Anti-CCP-Positive Rheumatoid Arthritis in Synergy With HLA-DRB1*04 and Smoking.
    Massarenti L, Enevold C, Damgaard D, Ødum N, Garred P, Frisch M, Shelef MA, Jacobsen S, Nielsen CH.
    Front Immunol; 2021 Nov 19; 12():707690. PubMed ID: 34733271
    [Abstract] [Full Text] [Related]

  • 19. PADI4 and the HLA-DRB1 shared epitope in juvenile idiopathic arthritis.
    Hisa K, Yanagimachi MD, Naruto T, Miyamae T, Kikuchi M, Hara R, Imagawa T, Yokota S, Mori M.
    PLoS One; 2017 Nov 19; 12(2):e0171961. PubMed ID: 28182665
    [Abstract] [Full Text] [Related]

  • 20. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles.
    Irigoyen P, Lee AT, Wener MH, Li W, Kern M, Batliwalla F, Lum RF, Massarotti E, Weisman M, Bombardier C, Remmers EF, Kastner DL, Seldin MF, Criswell LA, Gregersen PK.
    Arthritis Rheum; 2005 Dec 19; 52(12):3813-8. PubMed ID: 16320316
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 32.